Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the class of aromatic monoterpenoids, with the chemical formula C₁₇H₂₀N₂O₂ and a molecular weight of approximately 284.35 Da[1][3][6]. It is an experimental compound that has not been approved for clinical use in any country and has no known marketed formulations or brand names[1]. Structural studies indicate it can bind to nuclear receptors, specifically acting as a ligand for estrogen-related receptor gamma (ERRγ), suggesting potential activity as a modulator of this receptor[5]. Its primary research application is in structural biology and drug discovery, particularly related to nuclear hormone receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-hydroxy-N'-(4-isopropylbenzyl)benzohydrazide.